SEPTInvestingStart Free

VOR 8-K: Material agreement

Filed with the SEC on · accession 0001193125-26-456955

VOR filed a 8-K (current report) with the SEC on Nov 12, 2026. Vor Biopharma amended and restated its license agreement with RemeGen to add the dual-target fusion protein RC298 to its licensed portfolio, paying a $10 million upfront fee and issuing a pre-funded warrant for 2.3 million shares at $0.0001 per share.

Summary of the filing

Vor Biopharma amended and restated its license agreement with RemeGen to add the dual-target fusion protein RC298 to its licensed portfolio, paying a $10 million upfront fee and issuing a pre-funded warrant for 2.3 million shares at $0.0001 per share. The deal adds up to $300 million in development/commercial milestones and up to $3.775 billion in sales milestones for all licensed products.

For details, click here →How to read a 8-K →

Key details

Upfront cash payment to RemeGen$10.0M
Warrant shares issuable to RemeGenshares 2.3M
Warrant exercise price per share$0
Regulatory milestones for Initial Licensed Products$330.0M
Development and commercial milestones for Additional Licensed Products$300.0M
Sales milestones for all Licensed Products$3.8B
Licensee and issuer of warrantVor Biopharma Inc.
Licensor and warrant holderRemeGen Co., Ltd.

✦ Ask GOAX AI about this filing — what it means for VOR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VOR?

Click here

Frequently asked questions

What did VOR file with the SEC on Nov 12, 2026?

VOR filed a 8-K (Material agreement). Vor Biopharma amended and restated its license agreement with RemeGen to add the dual-target fusion protein RC298 to its licensed portfolio, paying a $10 million upfront fee and issuing a pre-funded warrant for 2.3 million shares at $0.0001 per share. The deal adds up to $300 million in development/commercial milestones and up to $3.775 billion in sales milestones for all licensed products.

What does a material agreement mean for VOR stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other VOR SEC filings

Get alerts when VOR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
VOR overviewVOR analysisVOR newsLatest SEC filings